SEC Form 4 · accession 0001178913-15-001598
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nadav Kidron
Officer — President and CEO · Director · 10% Owner
Period of report
May 12, 2015
Accepted (ET)
May 12, 2015 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2015 | P | 200 | $6.55 | A | 956,748 | D | |
| Common Stock | May 12, 2015 | P | 100 | $6.62 | A | 956,848 | D | |
| Common Stock | May 12, 2015 | P | 200 | $6.63 | A | 957,048 | D | |
| Common Stock | May 12, 2015 | P | 100 | $6.64 | A | 957,148 | D |
Table II — derivative securities
No Table II lines on this filing.